NCT04817644View on ClinicalTrials.gov

A Research Study to See How Much Semaglutide and SNAC is in the Milk of Healthy, Breastfeeding Women Taking Semaglutide Tablets

PHASE1CompletedINTERVENTIONAL

Enrollment

14

Participants

Timeline

Start Date

September 10, 2021

Primary Completion Date

May 26, 2023

Study Completion Date

July 3, 2023

Conditions

Diabetes Mellitus, Type 2

Interventions

DRUG

Oral semaglutide

Oral semaglutide once daily for a total of 10 days

Trial Locations (2)

78209

ICON Early Phase Services, LLC, San Antonio

84124

ICON-Salt Lake City, Salt Lake City

Sponsors

Lead Sponsor

Novo Nordisk A/S

All Listed Sponsors

lead

Novo Nordisk A/S

INDUSTRY

NCT04817644 - A Research Study to See How Much Semaglutide and SNAC is in the Milk of Healthy, Breastfeeding Women Taking Semaglutide Tablets | Biotech Hunter | Biotech Hunter